Low-energy photon emitting radionuclides encapsulated for a permanent impla
nt are routinely applied in prostate cancer brachytherapy. Before clinical
use, a new source design requires full dosimetric analysis and calibration
standardization. The results of one such experimental measurement and analy
sis are reported here for a new design of I-125 source, model I125-SL. Dose
measurements were made using standard methods employing thermoluminscent d
osimeters in a water equivalent plastic phantom, in accord with the AAPM Ta
sk Group #43 recommendation of liquid water reference material. Precision m
achined bores in the phantom located dosimeters and source(s) in a reproduc
ible fixed geometry providing for transverse-axis and angular dose profiles
over a range of distances from 0.17 to 10 cm. The data were analyzed in te
rms of parameters recommended by AAPM TG43. The dose-rate constant, Lambda,
was evaluated by two methods, the first with reference to a (60)Cobalt sta
ndard, accounting for response variation with photon energy spectrum. Secon
d, the dose-rate constant was determined with reference to phantom measurem
ents using NIST traceable calibrated model 6702 and 6711 sources. The radia
l dose function, g(r), the anisotropy function, F(r,theta), the anisotropy
factor, phi (an)(r), and the point-source approximation anisotropy constant
, <(<phi>)over bar>(an), were derived from one- and two-dimensional dose di
stribution data measured in the phantom, accounting for finite dosimeter vo
lume and with attention to interchip effects. The results are compared to T
G43 and other existing data for I-125 sources. The new source is comparable
to the model 6711 source design. (C) 2000 American Association of Physicis
ts in Medicine. [S0094-2405(00)00112-7].